PMA
P880064: HYPERTHERMIA SYSTEM 100 A
FDA PMA · Applicator, hyperthermia, superficial, rf/microwave · Medifocus, Inc.
Key facts
| PMA number | P880064 |
|---|---|
| Trade name | HYPERTHERMIA SYSTEM 100 A |
| Generic name | Applicator, hyperthermia, superficial, rf/microwave |
| Applicant | Medifocus, Inc. |
| Owner/operator | Medifocus Inc |
| Product code | LNC |
| Approval date | Nov 17, 1989 |
| Docket number | 90M-0058 |
| Notice date | Mar 8, 1990 |
| Establishment registration | 3009969279 |
| FEI number | 3009969279 |
At a glance
- 1–9 Supplements
- Sep 17, 1997 Latest supplement decision
- No Withdrawn
- No Summary of safety and effectiveness on file
- None UDI device identifiers (GUDID)
- None MAUDE adverse event reports
- None Recall events
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA approvals
Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: